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Abstract 
Electrographic Status epilepticus (SE) and myoclonus represent frequent findings in patients 
surviving cardiac arrest; both features have been related to poor clinical outcome. Recent data 
have outlined that SE appearing during therapeutic hypothermia and sedation is practically 
invariably related to a fatal issue, as opposed to some patients presenting SE and/or myoclonus 
after return to normothermic conditions. While it seems reasonable to give a chance of 
awakening to the latter patients by administering consequent antiepileptic treatment, especially if 
other favorable prognostic markers are observed, an aggressive treatment of SE arising during 
hypothermia seems futile in view of the existing evidence.  
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Background 
Despite recent advances in resuscitation and intensive care in the domain of hypoxic-ischemic 
encephalopathy after cardiac arrest [1], only about 5% of patients survive to hospital discharge 
[2], and several patients are left with long-term cognitive sequelae [3]. Outcome prediction in 
this clinical setting represents a daunting task for neurologists and intensivists; therefore, 
guidelines have been proposed, in which clinical examination and EEG represent paramount 
tools. As researchers have been particularly successful in refining prognostication for dismal 
prognosis [4], false-positive rates (FPR) for poor outcome prediction (Cerebral Performance 
Category of 3 or higher on  a scale of 5 [5]) should aim towards 0, with narrow confidence 
intervals. 
In 2006, the American Academy of Neurology published evidence-based practice parameters [6]. 
Early myoclonus within 24h of cardiac arrest (FPR=0), and an EEG with generalized 
suppression, burst-suppression, or periodic discharges on a suppressed background (FPR<5%), 
were reported as reliable markers of unfavorable prognosis (Level C); however, this analysis 
included almost exclusively subjects treated before the hypothermia era. 
 
Current evidence 
More recently, several studies conducted in different cohorts in Europe and North America have 
addressed the prognostic role of electrographic epileptiform abnormalities and clinical 
myoclonus in patients treated with controlled temperature management. For the purposes of this 
controversy, status epilepticus (SE) will be defined broadly as electroencephalographic evidence 
of repetitive (rhythmic, periodic, evolving) epileptiform transients over more than 5 minutes, and 
“aggressive” treatment as the use of prolonged pharmacological sedation to induce 
electrographic burst-suppression or complete suppression. 
After therapeutic hypothermia, electrographic seizures or repetitive epileptiform patterns are 
found in about 1/3 of adult patients [7-9], while early myoclonus (arising after weaning of 
sedation and hypothermia) has been reported in about 1/6 of patients [10, 11], and thus represent 
relatively frequent observations in this setting. Several independent investigators have found that 
the presence of EEG epileptiform alterations suggesting ongoing electrical seizures is 
incompatible with survival (FPR=0), even if patients were treated with antiepileptic drugs (AED) 
[9, 12-14]. 
However, several patients displaying postanoxic SE have in fact been reported to recover with at 
times a reasonable functional outcome [15, 16]. How is this to understand in view of the previous 
paragraph? To address this, at first glance, discrepancy, one should target her or his attention 
towards the early phase of intensive care, in which patients under hypothermia may undergo 
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EEG. Indeed, the extent of hypothermic EEG abnormalities (particularly, lack of background 
reactivity and discontinuity) has been shown to correlate with the magnitude of neuronal damage 
assessed with the neuron-specific enolase (NSE), a marker of neuronal death [17, 18]. A 
neurophysiologic, non-invasive tool may therefore prove highly informative, especially if 
recorded just after the first 9-12 hours following the initial insult [19]. 
During therapeutic hypothermia, recent evidence on 134 consecutive patients highlighted that the 
presence of epileptiform EEG activity is indeed not compatible with survival, even under 
continuous infusion of moderate doses of midazolam or propofol, and after additional AED 
treatment (FPR 0%); this contrasts with a FPR of 7% in patients displaying epileptiform activity 
only after return to normothermia, or the FPR of 13% for overt myoclonus within the first 48-72 
hours [10]. Of note, the lack of EEG background reactivity during hypothermia was also clearly 
related to a poor prognosis (FPR 2%) [10]. These findings are similar to those reported by 
another group on 56 subjects investigated with continuous EEG during hypo- and normothermia: 
epileptiform transients were found in 10% of the 22 patients with good neurological outcome, at 
48 hours (thus after hypothermia), but not under hypothermia, and lasted less than 2 hours under 
AED treatment [20]. A recent study focusing on postanoxic myoclonus highlighted that survival 
is clearly more frequent in patients without concomitant EEG epileptiform activity 
[11]Moreover, an earlier Scandinavian study conducted with amplitude-integrated EEG on 95 
patients demonstrated that among the 26 subjects with electrographic SE, the 2 who survived 
presented this condition only after return of normothermia, and out of a continuous background 
activity, but not burst-suppression [21]. Finally, occurrence of rhythmic, periodic, or ictal 
epileptiform features induced by stimulations, called “SIRPIDs” was recently assessed in a 
relatively large patient cohort: these were found in 13% of patients, and their occurrence during 
hypothermia was not compatible with survival [22]. 
 
Conclusions 
The aforementioned data seem to converge to the following three points. First, while 
electrographic epileptiform features, which nearly always present in a rhythmic or repetitive 
fashion at least for several hours [23], thus fulfilling the SE definition, are general markers of 
poor prognosis after cardiac arrest, their occurrence during the early resuscitation period, 
particularly under mild therapeutic hypothermia and sedation, has not been so far reported to be 
compatible with survival; this is in contrast with some patients who may benefit from AED 
treatment if their SE declares itself after return to normothermic conditions. It may be speculated 
that SE arising in hypothermia despite sedation is the hallmark of an agonal cortical activity 
resulting from a devastating brain insult [10], whereas SE appearing in normothermia may be 
sometimes amenable to treatment and a reasonable outcome. Second, EEG background reactivity 
represents a practical additional prognostic marker: its absence during hypothermia seems to 
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have a smaller FPR for poor outcome, as compared to normothermic conditions (FPR=7-9%) 
While EEG reactivity in this setting has recently been shown to have reasonable inter-rater 
agreements among EEG readers, and even with automated algorithms [24], another study found 
lower agreements [25]. Third, myoclonus, which is also consistently related to poor outcome, is 
nevertheless not an invariable marker of mortality; of note, sedation and muscle relaxants often 
prevent its observation during controlled temperature management.   
On top of these considerations, risks inherent to aggressive SE treatment, mostly related to 
potential complications of prolonged ICU treatment, sedation, and mechanical ventilation, have 
been outlined in recent literature, albeit outside of the setting of post-anoxic encephalopathy [26-
28]. 
It appears therefore reasonable to suggest the following approach in patients with hypoxic 
ischemic encephalopathy. If EEG features compatible with SE arise only after hypothermia and 
upon sedation weaning, on a reactive EEG in an otherwise potentially promising clinical context 
(e.g., return of brainstem reflexes, preserved cortical somatosensory evoked responses), a 
treatment with non-sedating and at times sedating AED seems warranted, at least for some days. 
If, conversely, SE appears during sedation and hypothermia on a non-reactive EEG background, 
aggressive antiepileptic treatment with long-term sedative agents appears futile, as can worsen 
comorbidities, may divert resources from patients who may better take advantage from intensive 
treatment, and might unnecessarily induce false expectations in relatives and caregivers.  
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